Climate change and air pollution negatively impact the health of patients with respiratory conditions – and yet some treatments used for those same conditions contribute to greenhouse gas emissions. Here, Dr David Lipson, GSK’s Vice President and Clinical Research Head, Respiratory and Immunology R&D, explains why a focus on sustainability in respiratory care is therefore essential – and how GSK is innovating to benefit both patients and the planet.
\nClimate change is one of the greatest threats to human health, and its impact on patients with respiratory health conditions should not be underestimated.
\nExtreme weather creates better conditions for respiratory infections to thrive in, while common pollutants, caused by things like vehicle exhausts and deforestation, can irritate the airways, sometimes with fatal results. It is estimated that air pollution is responsible for the premature deaths of around 7 million patients every year, whose ischemic heart disease, stroke, chronic obstructive pulmonary disease (COPD), lung cancer and acute respiratory infections are worsened by it.
\nAt the same time, we know that chronic respiratory treatments, like metered dose inhalers (MDIs), and hospitalisations are a large contributor to the carbon footprint of healthcare systems – which account for 4.4% of the global total of greenhouse gas emissions. To put it into perspective: if healthcare systems were a country, it would be the fifth largest emitter on the planet.
\nWe have been leaders in the prevention and treatment of respiratory disease for more than five decades. We have developed an industry leading approach to sustainability, with an ambition to achieve a 90% reduction in carbon emissions by 2045, as well as to contribute to a nature positive world, which includes company targets and action on water, waste, land use and biodiversity.
\nAs such, it makes sense that teams leading on respiratory care, like those at GSK, are determined to break this negative cycle by focusing on making respiratory care more sustainable.
","useGreyBackground":false,"fullWidth":false},{"type":"rich-text","text":"Embedding sustainability by design into new respiratory vaccines, medicines, packaging, and supply chains could significantly reduce impact on the environment.
\nThat’s why we’ve created ‘Sustainable Design Plans’ for all our newly developed or acquired medicines. These are now fully integrated to ensure we are building sustainability into the entire product design and development process.
\nDuring the drug development process, our Research and Development team apply principles of ‘green chemistry’, taking action to minimise the creation of waste and the amount of energy needed in the manufacturing process.
\nPlus we partner with industry peers to help our shared suppliers reduce their carbon emissions through programmes like Energize that make it easier for suppliers to access renewable electricity sources. And we’re working to reduce the environmental impact of our packaging by being a founding member of the Circularity in Primary Pharmaceutical Packaging Accelerator (CiPPPA), which brings together partners from across the sector to address the sustainable packaging of medicines and vaccines.
\nWe’re also applying these eco design principles to respiratory care. Metered dose inhalers (MDIs) are essential for many patients, but the propellants currently used in all MDIs to push the medicine into a person’s airways contributes to greenhouse gas emissions. We are currently in clinical trials looking at a next generation propellant, which, if successful, could reduce MDI emissions by approximately 90%.
\nAt the same time, we’re developing the next generation of respiratory treatments and preventions for millions of people with sustainability woven into every stage of the process – from the energy we use during discovery to the packaging it comes in and the way it is delivered.
","useGreyBackground":false,"fullWidth":false},{"type":"related-read-content","title":"Read related","relatedPage":{"title":"‘Patients can breathe easier today’: Scientific advances in asthma and COPD care could prevent irreversible lung damage","image":{"src":"/media/cjzfo0vx/gettyimages-1301122401.jpg?format=webp&v=1dba2eb9c20c850&hmac=15278bf6187dfd95cefb198836c1b564bea46320bacd9797a8d8fa11d99b4632","alt":"Person points to X-ray image of lungs","darkModeSrc":"/media/cjzfo0vx/gettyimages-1301122401.jpg?format=webp&quality=50&v=1dba2eb9c20c850&hmac=895fbbd237025c64ae580e1bf1258dd88a815e41e719baa0bd73099ee0ea3751"},"link":{"text":"asthma copd treatment prevent lung damage","href":"/en-gb/behind-the-science-magazine/asthma-copd-treatment-prevent-lung-damage/","openInNewWindowText":null},"label":"Behind the Science magazine","authorName":null}},{"type":"rich-text","text":"Intervening earlier in the course of respiratory disease is another way we can protect patients and the planet.
\nAsthma and COPD are both chronic inflammatory conditions driven by genetic and environmental factors. As such, they are complex and often poorly controlled, leading to increased treatments, doctor visits and hospitalisations, all of which are key drivers of greenhouse gas emissions within healthcare systems.
\nEarlier diagnosis and improved, patient-centred treatment regimens that consider the biological uniqueness of an individual’s respiratory disease can potentially reduce the risk of exacerbations – or attacks – and permanent damage to the lungs. This can help patients manage their symptoms more effectively, keeping them out of hospital and preventing them from developing comorbidities that could end up needing more treatment.
\nWe also have an opportunity to make better use of treatment innovations to optimise patient care and therefore reduce the impact of traditional care on the environment. For example, where appropriate, patients can be prescribed advanced longer-acting therapies, or a propellant-free Dry Powder Inhaler (DPI), both of which can help them achieve clinical benefits while significantly cutting carbon emissions.
\nAnd it’s important to protect patients against common respiratory diseases through vaccination, as they are more likely to develop severe complications from infections. This is better for patient outcomes, and emerging data shows that preventing diseases through vaccination is far more sustainable than treating disease.
","useGreyBackground":false,"fullWidth":false},{"type":"related-read-content","title":"Read related","relatedPage":{"title":"In the face of climate change, vaccines play a crucial but underestimated role","image":{"src":"/media/kpqdyv1e/global-health_kenya_22-002.jpg?format=webp&v=1dba2eb9cbfee80&hmac=06324dad91c01434086bb5417e9644d74ce7b2d0538fec402aaebc74a13f644e","alt":"Adult and toddler in Kenya","darkModeSrc":"/media/kpqdyv1e/global-health_kenya_22-002.jpg?format=webp&quality=50&v=1dba2eb9cbfee80&hmac=5f263e0a7cc6a13f13d9f794d20f6acffaa3c4c61a35aa6e9b7a1f05bb060899"},"link":{"text":"vaccines climate change health economy","href":"/en-gb/behind-the-science-magazine/vaccines-climate-change-health-economy/","openInNewWindowText":null},"label":"Behind the Science magazine","authorName":null}},{"type":"rich-text","text":"But we can’t do it alone.
\nThe path to delivering more sustainable respiratory care must involve partners across the healthcare system pulling together: from industry collaboration to change supply chains, to teaming up with regulators and payers to ensure the uptake of sustainable medicines and vaccines. We also need to support healthcare professionals to prescribe sustainable treatments and patients to use them.
\nThe challenge might be complex, but we share the same air and the same goal – better health outcomes with a lower impact on our environment.
\nTogether we can deliver solutions that move us forward towards a respiratory care that is better for both patients and the planet.
","useGreyBackground":false,"fullWidth":false},{"type":"author","name":"Dr David Lipson","readTimeSuffix":"min read time","readMoreText":"See more from this author","jobTitle":"Vice President and Clinical Research Head, Respiratory and Immunology R&D at GSK","bio":"Dr David Lipson supports the development of the respiratory disease area strategy and helps oversee the clinical studies and expansion activities for the GSK respiratory portfolio. David works closely with members of the early research group helping to design the development plans for early assets within the GSK pipeline, and reviews respiratory business development opportunities to further expand the respiratory portfolio. He is also an Adjunct Associate Professor of Medicine at the Perelman School of Medicine, University of Pennsylvania.","profilePicture":{"src":"/media/ocehjuh4/lipson-crop.png?width=400&height=400&format=webp&quality=100&v=1dba2eb9962e0d0&hmac=2c98bb1d6da4c9f6992514a983f5f71e707c3037d9b9ccdab26a77bd531dbf24","alt":"Man in suit sitting in front of bookshelf","darkModeSrc":"/media/ocehjuh4/lipson-crop.png?width=400&height=400&format=webp&quality=50&v=1dba2eb9962e0d0&hmac=0efbd3369897933b346f0a4b0328a433bf5e81acba93634a8e45393f2d789f6d"},"otherArticles":[{"headline":"‘Putting patients first means caring about the air they breathe – and reducing the impact of respiratory care on the environment’","href":"/en-gb/behind-the-science-magazine/respiratory-disease-sustainability-climate-change/","thumbnail":{"src":"/media/pwugpq2r/patientinnaturerespisustainabilityshutterstock.jpg?rxy=0.66833333333333333,0.525&width=215&height=215&format=webp&quality=100&v=1dba2eb9a201650&hmac=e5a5b22dc09abec4f18efa5a5615ed8206f2ca2a5252fabcd5d1ed3f679f7b0a","alt":"Woman and child riding a bike","darkModeSrc":"/media/pwugpq2r/patientinnaturerespisustainabilityshutterstock.jpg?rxy=0.66833333333333333,0.525&width=215&height=215&format=webp&quality=50&v=1dba2eb9a201650&hmac=5afdb60c1d99b309ec5629063e6092cbcabc060fd6dfff71a0b1260939895180"},"datePublished":"04 September 2024","articleType":"Opinion","readTimeMins":3,"readTimeSuffix":"min read time","author":{"name":"Dr David Lipson","jobTitle":"Vice President and Clinical Research Head, Respiratory and Immunology R&D at GSK","bio":"Dr David Lipson supports the development of the respiratory disease area strategy and helps oversee the clinical studies and expansion activities for the GSK respiratory portfolio. David works closely with members of the early research group helping to design the development plans for early assets within the GSK pipeline, and reviews respiratory business development opportunities to further expand the respiratory portfolio. He is also an Adjunct Associate Professor of Medicine at the Perelman School of Medicine, University of Pennsylvania.","readMoreText":"See more from this author","profilePicture":{"src":"/media/ocehjuh4/lipson-crop.png?width=400&height=400&format=webp&quality=100&v=1dba2eb9962e0d0&hmac=2c98bb1d6da4c9f6992514a983f5f71e707c3037d9b9ccdab26a77bd531dbf24","alt":"Man in suit sitting in front of bookshelf","darkModeSrc":"/media/ocehjuh4/lipson-crop.png?width=400&height=400&format=webp&quality=50&v=1dba2eb9962e0d0&hmac=0efbd3369897933b346f0a4b0328a433bf5e81acba93634a8e45393f2d789f6d"},"otherArticles":null,"key":"3e7e23da-7a18-4811-978a-2021ed33e0a8"}}]},{"type":"varied-signpost-grid","title":"","layoutPattern":4,"pages":[{"title":"‘My cough interferes with everything’: New research could help refractory chronic cough patients after decades of depression, pain, and sleep loss","content":"GSK scientists are working on new areas of research that could bring relief to millions of refractory chronic cough patients","image":{"src":"/media/sq1haokl/getty-image-rcc-bts-article-gsk-camli.jpg?width=427&height=533&format=webp&quality=100&v=1dba2eb9a89d4a0&hmac=eabc6c20d8709ef75651a355f448beb400998f581d1f91f956a8ae9bf6421bf0","alt":"Person coughs in bedroom","darkModeSrc":"/media/sq1haokl/getty-image-rcc-bts-article-gsk-camli.jpg?width=427&height=533&format=webp&quality=50&v=1dba2eb9a89d4a0&hmac=adbb8b4db5b8d6c2d9c10a6df31841f5d15d6566207818d6297b2b4ff47c38f8"},"link":{"text":"refractory chronic cough patients symptoms","href":"/en-gb/behind-the-science-magazine/refractory-chronic-cough-patients-symptoms/","openInNewWindowText":null}},{"title":"6 in 10 of adults over 50 have never heard of RSV, despite some being among those most at risk of infection","content":"RSV is a leading cause of respiratory illness in adults, yet new survey data shows many do not know it exists","image":{"src":"/media/f4zobbvr/shutterstock_2228396077.jpg?width=427&height=533&format=webp&quality=100&v=1dba2eb9a459fb0&hmac=36d6a24c77195660f3f15c0514505f87efe6afc2cb5e40dd18a64045e93b741e","alt":"Large crowd of people","darkModeSrc":"/media/f4zobbvr/shutterstock_2228396077.jpg?width=427&height=533&format=webp&quality=50&v=1dba2eb9a459fb0&hmac=150efa14a55f84bcba43518fc4f824daaf4ffa31e6fb83d2618c43c7dce37a85"},"link":{"text":"rsv survey data symptoms risk","href":"/en-gb/behind-the-science-magazine/rsv-survey-data-symptoms-risk/","openInNewWindowText":null}},{"title":"Remission could be possible for people with asthma, giving them a new outlook on life","content":"Global specialists, including GSK scientists, are applying years of expertise in asthma to aspire to clinical remission.","image":{"src":"/media/0n3je2ne/remission-update.jpg?width=427&height=533&format=webp&quality=100&v=1dba2eb9f4b0630&hmac=bcc08ac42b155c4c02bb07d8d65b2ca4989b606913a6e188b05f6ebc1e4a7544","alt":"Woman using asthma inhaler","darkModeSrc":"/media/0n3je2ne/remission-update.jpg?width=427&height=533&format=webp&quality=50&v=1dba2eb9f4b0630&hmac=8717339994cf12823c08bbf87ebae379c9e518b585000f051f5bb11edd9250c2"},"link":{"text":"remission severe asthma treatments possible","href":"/en-gb/behind-the-science-magazine/remission-severe-asthma-treatments-possible/","openInNewWindowText":null}}],"hidePageDescription":true,"useGreyBackground":false}]},"id":6345,"docCheckLogout":null,"pageType":"magazinePage","languageCode":"en-GB","theme":"light","breadcrumb":{"ariaLabel":"Breadcrumb","links":[{"text":"Home","href":"/en-gb/","openInNewWindowText":null},{"text":"Behind the Science magazine","href":"/en-gb/behind-the-science-magazine/","openInNewWindowText":null},{"text":"‘Putting patients first means caring about the air they breathe – and reducing the impact of respiratory care on the environment’","href":"/en-gb/behind-the-science-magazine/respiratory-disease-sustainability-climate-change/","openInNewWindowText":null}]},"pageName":"‘Putting patients first means caring about the air they breathe – and reducing the impact of respiratory care on the environment’","topNav":{"homeLink":{"text":"GSK Homepage","href":"/en-gb/","openInNewWindowText":null},"topBar":{"currentLocation":{"isGlobal":true,"text":"Global"},"languageSelector":{"currentLanguage":null,"currentLanguageMobile":null,"selectableLanguages":[]},"darkModeSwitch":{"text":"Dark mode","tooltipText":"Switch to dark mode to head towards a more sustainable world together. More info
"},"globalSiteLink":null,"locationSelector":{"text":"Change location","href":"/en-gb/locations/","openInNewWindowText":null},"healthCareLink":{"text":"Healthcare professionals","href":"https://www.gskpro.com","target":"_blank","openInNewWindowText":"Opens in a new window"},"contactUs":{"text":"Contact us","href":"/en-gb/contact-us/","openInNewWindowText":null},"search":"Search","backToMain":"Back to main","menu":"Menu","closeMenu":"Close menu","animationsToggleModel":{"enable":true,"activeText":"Pause video","inactiveText":"Play video"}},"nodes":[{"tooltip":null,"hasBorderRight":true,"title":"Behind the Science magazine","url":"/en-gb/behind-the-science-magazine/","nodes":[],"isActive":true,"promos":[]},{"tooltip":null,"hasBorderRight":false,"title":"Company","url":"/en-gb/company/","nodes":[{"title":"Purpose, strategy and culture","url":"/en-gb/company/purpose-strategy-and-culture/","nodes":[],"isActive":false},{"title":"GSK at a glance","url":"/en-gb/company/gsk-at-a-glance/","nodes":[],"isActive":false},{"title":"History and heritage","url":"/en-gb/company/history-and-heritage/","nodes":[],"isActive":false},{"title":"Board of Directors and Executive Committee","url":"/en-gb/company/board-of-directors-and-leadership-team/","nodes":[],"isActive":false},{"title":"Board information","url":"/en-gb/company/board-information/","nodes":[],"isActive":false},{"title":"Governance","url":"/en-gb/company/governance/","nodes":[{"title":"Committees","url":"/en-gb/company/governance/committees/","nodes":[],"isActive":false},{"title":"Shareholders","url":"/en-gb/company/governance/shareholders/","nodes":[],"isActive":false},{"title":"Sarbanes-Oxley Act 2002","url":"/en-gb/company/governance/sarbanes-oxley-act-2002/","nodes":[],"isActive":false},{"title":"Compliance","url":"/en-gb/company/governance/compliance/","nodes":[],"isActive":false}],"isActive":false},{"title":"Policy positions","url":"/en-gb/company/policy-positions/","nodes":[],"isActive":false},{"title":"Codes, standards and reports","url":"/en-gb/company/codes-standards-and-reports/","nodes":[],"isActive":false}],"isActive":false,"promos":[{"text":"Our purpose, strategy and culture","image":{"src":"/media/vvwddvsg/gsk_tech_human_image_6k.jpg?rxy=0.56833333333333336,0.30177514792899407&width=329&height=185&format=webp&quality=100&v=1dba2ec0bc1e680&hmac=13d78c5b371b5e09f560d958dfb6a3b8cb27a35b1578669ba061acc1b12273dd","alt":"GSK Tech Human Image","darkModeSrc":"/media/vvwddvsg/gsk_tech_human_image_6k.jpg?rxy=0.56833333333333336,0.30177514792899407&width=329&height=185&format=webp&quality=50&v=1dba2ec0bc1e680&hmac=7971e77f08fa2cbbfcb2e6dff5010e3d9c37f8561060dfbcdc7ec38ac7e5f314"},"link":{"text":"FEATURED SECTION","href":"/en-gb/company/purpose-strategy-and-culture/","openInNewWindowText":null}},{"text":"Outstanding people","image":{"src":"/media/kgwp0dc5/sddefault-2.jpg?rxy=0.425,0.51807228915662651&width=329&height=185&format=webp&quality=100&v=1dba2eba773f3d0&hmac=9e8e9da5bd3ca0619cfd47c6274f5ecbae61a5b73808bbd57b4fdffa469f2037","alt":"Angeles sitting on a sofa in a pink shirt","darkModeSrc":"/media/kgwp0dc5/sddefault-2.jpg?rxy=0.425,0.51807228915662651&width=329&height=185&format=webp&quality=50&v=1dba2eba773f3d0&hmac=25f6331ff89b8ea1f896e23e1cc935cee241b346efb1b08bd5aa5b5aa0d4e09c"},"link":{"text":"FEATURED SECTION","href":"/en-gb/careers/outstanding-people/","openInNewWindowText":null}}]},{"tooltip":null,"hasBorderRight":false,"title":"Innovation","url":"/en-gb/innovation/","nodes":[{"title":"Our leading scientists","url":"/en-gb/innovation/our-leading-scientists/","nodes":[{"title":"Dr Tony Wood","url":"/en-gb/innovation/our-leading-scientists/tony-wood/","nodes":[],"isActive":false},{"title":"Dr Sabine Luik","url":"/en-gb/innovation/our-leading-scientists/sabine-luik/","nodes":[],"isActive":false},{"title":"Dr Hesham Ahmed Abdullah","url":"/en-gb/innovation/our-leading-scientists/hesham-abdullah/","nodes":[],"isActive":false},{"title":"Dr Kaivan Khavandi","url":"/en-gb/innovation/our-leading-scientists/kaivan-khavandi/","nodes":[],"isActive":false},{"title":"Dr Christopher Austin","url":"/en-gb/innovation/our-leading-scientists/dr-christopher-austin/","nodes":[],"isActive":false},{"title":"Charlotte Allerton","url":"/en-gb/innovation/our-leading-scientists/charlotte-allerton/","nodes":[],"isActive":false}],"isActive":false},{"title":"Research and development approach","url":"/en-gb/innovation/research-and-development-approach/","nodes":[],"isActive":false},{"title":"Pipeline","url":"/en-gb/innovation/pipeline/","nodes":[],"isActive":false},{"title":"Therapeutic areas","url":"/en-gb/innovation/therapeutic-areas/","nodes":[{"title":"Respiratory, immunology and inflammation","url":"/en-gb/innovation/therapeutic-areas/respiratory-immunology-and-inflammation/","nodes":[],"isActive":false},{"title":"Oncology","url":"/en-gb/innovation/therapeutic-areas/oncology/","nodes":[],"isActive":false},{"title":"HIV","url":"/en-gb/innovation/therapeutic-areas/hiv/","nodes":[],"isActive":false},{"title":"Infectious diseases","url":"/en-gb/innovation/therapeutic-areas/infectious-diseases/","nodes":[],"isActive":false}],"isActive":false},{"title":"Tech","url":"/en-gb/innovation/technologies/","nodes":[{"title":"Post-quantum cryptography","url":"/en-gb/innovation/technologies/post-quantum-cryptography/","nodes":[],"isActive":false}],"isActive":false},{"title":"Clinical trials at GSK","url":"/en-gb/innovation/trials/","nodes":[{"title":"Provision of unapproved medicines for unmet medical needs","url":"/en-gb/innovation/trials/provision-of-unlicensed-medicines-for-unmet-medical-needs/","nodes":[],"isActive":false},{"title":"Data transparency","url":"/en-gb/innovation/trials/data-transparency/","nodes":[],"isActive":false},{"title":"Representative clinical studies","url":"/en-gb/innovation/trials/representative-clinical-studies/","nodes":[],"isActive":false}],"isActive":false},{"title":"Partnering with GSK","url":"/en-gb/innovation/partnerships/","nodes":[{"title":"Supported studies","url":"/en-gb/innovation/partnerships/supported-studies/","nodes":[],"isActive":false}],"isActive":false},{"title":"R&D locations","url":"/en-gb/innovation/rd-locations/","nodes":[],"isActive":false}],"isActive":false,"promos":[{"text":"Behind the science magazine","image":{"src":"/media/ukvllwft/vaccine-manufacturing-production-line-2.jpg?width=329&height=185&format=webp&quality=100&v=1dba2ebb585f130&hmac=c3e21840aa4184183d7a56b6b9e51c276f4c0cfa99faddf0b2e96abade984999","alt":"Scientist works in a futurist vaccine laboratory for GSK","darkModeSrc":"/media/ukvllwft/vaccine-manufacturing-production-line-2.jpg?width=329&height=185&format=webp&quality=50&v=1dba2ebb585f130&hmac=1ee1d1cba0cbe920daab92982b410dfd5be6b812ffb18d46bc5a1b15dc8ea9e4"},"link":{"text":"SPOTLIGHT ON","href":"/en-gb/behind-the-science-magazine/","openInNewWindowText":null}},{"text":"Our leading scientists","image":{"src":"/media/45khexa4/tony-16x9.jpg?rxy=0.5733215608441357,0.39891812701082546&width=329&height=185&format=webp&quality=100&v=1dc651e856734f0&hmac=89240d0220a7a43a3ae9394fb29afbab3cb4192dc9283cc81575d646ff2c2d97","alt":"Tony Wood","darkModeSrc":"/media/45khexa4/tony-16x9.jpg?rxy=0.5733215608441357,0.39891812701082546&width=329&height=185&format=webp&quality=50&v=1dc651e856734f0&hmac=aa2617bc227baad2755a0fb9ad1fbe695d7cd6bbae99b54a174e6ece08ac6f3f"},"link":{"text":"Featured section","href":"/en-gb/innovation/our-leading-scientists/","openInNewWindowText":null}}]},{"tooltip":null,"hasBorderRight":false,"title":"Products","url":"/en-gb/products/","nodes":[{"title":"Product areas","url":"/en-gb/products/our-product-areas/","nodes":[],"isActive":false},{"title":"Products A-Z","url":"/en-gb/products/products-a-z/","nodes":[],"isActive":false}],"isActive":false,"promos":[{"text":"Innovation","image":{"src":"/media/jxkd3fld/web03-header-stvg_2_2022_port_5_hess_nav.jpg?width=329&height=185&format=webp&quality=100&v=1dba2ebbe22d650&hmac=7e7c4f7e55d1c5f8195a127fe9f281066fa29131749b341d38ddb0d073a8c08e","alt":"Lab technician leaning against wall","darkModeSrc":"/media/jxkd3fld/web03-header-stvg_2_2022_port_5_hess_nav.jpg?width=329&height=185&format=webp&quality=50&v=1dba2ebbe22d650&hmac=a094b899394c4bc9edc97886a222232920b438f99f396aadeb7e3b2848f7ee89"},"link":{"text":"SPOTLIGHT ON","href":"/en-gb/innovation/","openInNewWindowText":null}},{"text":"GSKPro for healthcare professionals ","image":{"src":"/media/xpibjmpq/navthumb_stvg_03_2022_port_32_eagle_orange-1.jpg?width=329&height=185&format=webp&quality=100&v=1dba2ebbe35c210&hmac=2075d37c23b475f2bc9ac77a07adcafcd381777fce6f7d574009e72fff69ff1f","alt":"Two scientists on orange background","darkModeSrc":"/media/xpibjmpq/navthumb_stvg_03_2022_port_32_eagle_orange-1.jpg?width=329&height=185&format=webp&quality=50&v=1dba2ebbe35c210&hmac=e50f7e49e96007544857017de5b32764327c6f3fd6d677c14972001d3b9771c4"},"link":{"text":"FEATURED WEBSITE","href":"https://gskpro.com","target":"_blank","openInNewWindowText":"Opens in a new window"}}]},{"tooltip":null,"hasBorderRight":true,"title":"Responsibility","url":"/en-gb/responsibility/","nodes":[{"title":"Access","url":"/en-gb/responsibility/access/","nodes":[],"isActive":false},{"title":"Global health and health security","url":"/en-gb/responsibility/global-health-and-health-security/","nodes":[{"title":"Global health","url":"/en-gb/responsibility/global-health-and-health-security/global-health/","nodes":[],"isActive":false},{"title":"Health security","url":"/en-gb/responsibility/global-health-and-health-security/health-security/","nodes":[],"isActive":false},{"title":"Using our science for global health","url":"/en-gb/responsibility/global-health-and-health-security/using-our-science-for-global-health/","nodes":[],"isActive":false},{"title":"Improving access to healthcare","url":"/en-gb/responsibility/global-health-and-health-security/improving-access-to-healthcare/","nodes":[],"isActive":false},{"title":"Africa Open Lab","url":"/en-gb/responsibility/global-health-and-health-security/africa-open-lab/","nodes":[],"isActive":false}],"isActive":false},{"title":"Environment","url":"/en-gb/responsibility/environment/","nodes":[{"title":"Climate","url":"/en-gb/responsibility/environment/climate/","nodes":[],"isActive":false},{"title":"Freshwater","url":"/en-gb/responsibility/environment/freshwater/","nodes":[],"isActive":false},{"title":"Land","url":"/en-gb/responsibility/environment/land/","nodes":[],"isActive":false},{"title":"Oceans","url":"/en-gb/responsibility/environment/oceans/","nodes":[],"isActive":false},{"title":"Materials and waste","url":"/en-gb/responsibility/environment/materials-and-waste/","nodes":[],"isActive":false},{"title":"Health system sustainability","url":"/en-gb/responsibility/environment/health-system-sustainability/","nodes":[],"isActive":false}],"isActive":false},{"title":"Inclusion","url":"/en-gb/responsibility/inclusion/","nodes":[],"isActive":false},{"title":"Ethical standards","url":"/en-gb/responsibility/ethical-standards/","nodes":[{"title":"Working with third parties","url":"/en-gb/responsibility/ethical-standards/working-with-third-parties/","nodes":[],"isActive":false},{"title":"Public policy and patient advocacy","url":"/en-gb/responsibility/ethical-standards/public-policy-and-patient-advocacy/","nodes":[],"isActive":false},{"title":"Human rights","url":"/en-gb/responsibility/ethical-standards/human-rights/","nodes":[],"isActive":false},{"title":"Use of animals","url":"/en-gb/responsibility/ethical-standards/use-of-animals/","nodes":[],"isActive":false},{"title":"Engaging with healthcare professionals","url":"/en-gb/responsibility/ethical-standards/engaging-with-healthcare-professionals/","nodes":[],"isActive":false}],"isActive":false},{"title":"Product governance","url":"/en-gb/responsibility/product-governance/","nodes":[],"isActive":false},{"title":"Grants and donations","url":"/en-gb/responsibility/grants-and-donations/","nodes":[],"isActive":false},{"title":"Charitable investments ","url":"/en-gb/responsibility/charitable-investments/","nodes":[],"isActive":false},{"title":"Responsibility reports","url":"/en-gb/responsibility/responsibility-reports/","nodes":[{"title":"Reports archive","url":"/en-gb/responsibility/responsibility-reports/responsibility-reports-archive/","nodes":[],"isActive":false}],"isActive":false}],"isActive":false,"promos":[{"text":"Inclusion","image":{"src":"/media/2u2dowa1/web16-header-stvg_2_2022_port_13_hess_nav.jpg?width=329&height=185&format=webp&quality=100&v=1dba2ebc1b88030&hmac=12ac7ded8bd7ab6e4665214fcc035ed44c079abcb2fbda20ea2220be73c1f12e","alt":"Lab technician smiling","darkModeSrc":"/media/2u2dowa1/web16-header-stvg_2_2022_port_13_hess_nav.jpg?width=329&height=185&format=webp&quality=50&v=1dba2ebc1b88030&hmac=a50405e6d858c131f8bc642c26ae3a9fb06154803458a748320a0ff3ec9c7e2f"},"link":{"text":"FEATURED SECTION","href":"/en-gb/responsibility/inclusion/","openInNewWindowText":null}},{"text":"Our policy positions","image":{"src":"/media/110ltmz5/gsk_texture_fluid_03_a_cmyk_web-size_nav.jpg?width=329&height=185&format=webp&quality=100&v=1dba2ebbe9b61b0&hmac=9e323e7d55541fa849cbe984c44f8a60da1e99fe2119d3c3fb9efb2dda7b58a8","alt":"GSK orange texture","darkModeSrc":"/media/110ltmz5/gsk_texture_fluid_03_a_cmyk_web-size_nav.jpg?width=329&height=185&format=webp&quality=50&v=1dba2ebbe9b61b0&hmac=322065363b28083d211d5e68d0cffdbb01a506045f8e286c0284e908ea0a5805"},"link":{"text":"SPOTLIGHT ON","href":"/en-gb/company/policy-positions/","openInNewWindowText":null}}]},{"tooltip":null,"hasBorderRight":false,"title":"Investors","url":"/en-gb/investors/","nodes":[{"title":"Why invest in GSK?","url":"/en-gb/investors/why-invest-in-gsk/","nodes":[],"isActive":false},{"title":"Quarterly results","url":"/en-gb/investors/quarterly-results/","nodes":[],"isActive":false},{"title":"Financial reports","url":"/en-gb/investors/financial-reports/","nodes":[{"title":"Annual Report 2025","url":"/en-gb/investors/financial-reports/annual-report-2025/","nodes":[],"isActive":false},{"title":"Corporate reports archive","url":"/en-gb/investors/financial-reports/corporate-reports-archive/","nodes":[],"isActive":false}],"isActive":false},{"title":"Responsible business","url":"/en-gb/investors/responsible-business/","nodes":[],"isActive":false},{"title":"Speeches and presentations","url":"/en-gb/investors/speeches-and-presentations/","nodes":[],"isActive":false},{"title":"Science publications","url":"/en-gb/investors/science-publications/","nodes":[],"isActive":false},{"title":"Events calendar","url":"/en-gb/investors/events-calendar/","nodes":[],"isActive":false},{"title":"Dividend and share price","url":"/en-gb/investors/dividend-and-share-price/","nodes":[{"title":"GSK share price","url":"/en-gb/investors/dividend-and-share-price/gsk-share-price/","nodes":[],"isActive":false},{"title":"Share price calculators (GBp/USD)","url":"/en-gb/investors/dividend-and-share-price/share-price-calculators-gbpusd/","nodes":[],"isActive":false},{"title":"Dividend calculators (GBp/USD)","url":"/en-gb/investors/dividend-and-share-price/dividend-calculators-gbpusd/","nodes":[],"isActive":false},{"title":"Dividend calendar","url":"/en-gb/investors/dividend-and-share-price/dividend-calendar/","nodes":[],"isActive":false}],"isActive":false},{"title":"Analyst consensus","url":"/en-gb/investors/analyst-consensus/","nodes":[],"isActive":false},{"title":"Stock exchange announcements","url":"/en-gb/investors/stock-exchange-announcements/","nodes":[{"title":"London (RNS)","url":"/en-gb/investors/stock-exchange-announcements/london-rns/","nodes":[],"isActive":false},{"title":"London (RNS) inside information","url":"/en-gb/investors/stock-exchange-announcements/london-rns-inside-information/","nodes":[],"isActive":false},{"title":"New York (SEC)","url":"/en-gb/investors/stock-exchange-announcements/new-york-sec/","nodes":[],"isActive":false},{"title":"Sign up for announcements","url":"/en-gb/investors/stock-exchange-announcements/sign-up-for-announcements/","nodes":[],"isActive":false}],"isActive":false},{"title":"Shareholder information","url":"/en-gb/investors/shareholder-information/","nodes":[{"title":"Manage your shares","url":"/en-gb/investors/shareholder-information/manage-your-shares/","nodes":[],"isActive":false},{"title":"Annual General Meeting","url":"/en-gb/investors/shareholder-information/annual-general-meeting/","nodes":[],"isActive":false},{"title":"General Meeting","url":"/en-gb/investors/shareholder-information/general-meeting/","nodes":[],"isActive":false},{"title":"Annual Governance Meeting","url":"/en-gb/investors/shareholder-information/annual-governance-meeting/","nodes":[],"isActive":false},{"title":"Corporate sponsored nominee service","url":"/en-gb/investors/shareholder-information/corporate-sponsored-nominee-service/","nodes":[],"isActive":false},{"title":"Our ADR programme","url":"/en-gb/investors/shareholder-information/adr-programme/","nodes":[],"isActive":false},{"title":"Asset reunification - Georgeson ","url":"/en-gb/investors/shareholder-information/asset-reunification-georgeson/","nodes":[],"isActive":false},{"title":"Share scam alert","url":"/en-gb/investors/shareholder-information/share-scam-alert/","nodes":[],"isActive":false},{"title":"Privacy notice for ordinary shareholders","url":"/en-gb/investors/shareholder-information/privacy-notice-for-ordinary-shareholders/","nodes":[],"isActive":false},{"title":"FAQs","url":"/en-gb/investors/shareholder-information/shareholder-faqs/","nodes":[],"isActive":false}],"isActive":false},{"title":"Corporate actions","url":"/en-gb/investors/corporate-actions/","nodes":[{"title":"Consumer Healthcare Demerger","url":"/en-gb/investors/corporate-actions/consumer-healthcare-demerger/","nodes":[],"isActive":false},{"title":"Consumer Healthcare Joint Venture","url":"/en-gb/investors/corporate-actions/consumer-healthcare-joint-venture/","nodes":[],"isActive":false},{"title":"Agreement to acquire TESARO","url":"/en-gb/investors/corporate-actions/agreement-to-acquire-tesaro/","nodes":[],"isActive":false}],"isActive":false},{"title":"Debt investors","url":"/en-gb/investors/debt-investors/","nodes":[],"isActive":false},{"title":"Investor contacts","url":"/en-gb/investors/investor-contacts/","nodes":[],"isActive":false}],"isActive":false,"promos":[{"text":"Press releases","image":{"src":"/media/hb1dfygw/ware_3_2022_prodassmb_28_hess_nav.jpeg?width=329&height=185&format=webp&quality=100&v=1dba2ebc6f12bb0&hmac=f3dda3c7bd6599a1c2f05133bb899c647be6962b177d4b772cd87d676c8a7d94","alt":"Lab machinery","darkModeSrc":"/media/hb1dfygw/ware_3_2022_prodassmb_28_hess_nav.jpeg?width=329&height=185&format=webp&quality=50&v=1dba2ebc6f12bb0&hmac=39e1b2702e8059aa94f14c98a803dbe514bde3cb0ae2d3d2fd23a6e78c938b52"},"link":{"text":"SPOTLIGHT ON","href":"/en-gb/media/press-releases/","openInNewWindowText":null}},{"text":"Our pipeline","image":{"src":"/media/2kyan0vw/ware_3_2022_prodqc_14_hess.jpeg?width=329&height=185&format=webp&quality=100&v=1dba2ebc701f490&hmac=bf2488fd39b58115ffca972c3b022be99778cb82fc5a894714dd3d84863ed736","alt":"Case of vials","darkModeSrc":"/media/2kyan0vw/ware_3_2022_prodqc_14_hess.jpeg?width=329&height=185&format=webp&quality=50&v=1dba2ebc701f490&hmac=31c09472f1b12264f8141bef8b943a0354c076daf5ec330cb2322259c29365b9"},"link":{"text":"SPOTLIGHT ON","href":"/en-gb/innovation/pipeline/","openInNewWindowText":null}}]},{"tooltip":null,"hasBorderRight":false,"title":"Media","url":"/en-gb/media/","nodes":[{"title":"Press releases","url":"/en-gb/media/press-releases/","nodes":[],"isActive":false},{"title":"Media contacts","url":"/en-gb/media/media-contacts/","nodes":[],"isActive":false},{"title":"Media library","url":"/en-gb/media/media-library/","nodes":[],"isActive":false},{"title":"Media statements","url":"/en-gb/media/media-statements/","nodes":[{"title":"Zantac litigation","url":"/en-gb/media/media-statements/zantac-litigation/","nodes":[],"isActive":false},{"title":"GSK's position on Flovent","url":"/en-gb/media/media-statements/gsks-position-on-flovent/","nodes":[],"isActive":false},{"title":"GSK-developed TB vaccine candidate progresses toward global access with new manufacturing agreement ","url":"/en-gb/media/media-statements/gsk-developed-tb-vaccine-candidate-progresses-toward-global-access-with-new-manufacturing-agreement/","nodes":[],"isActive":false},{"title":"GSK tops Antimicrobial Resistance (AMR) Benchmark Report","url":"/en-gb/media/media-statements/gsk-tops-antimicrobial-resistance-amr-benchmark-report/","nodes":[],"isActive":false}],"isActive":false},{"title":"Our social media","url":"/en-gb/media/social-media/","nodes":[],"isActive":false},{"title":"Podcasts","url":"/en-gb/media/podcasts/","nodes":[],"isActive":false},{"title":"RSS feeds","url":"/en-gb/media/rss-feeds/","nodes":[],"isActive":false}],"isActive":false,"promos":[{"text":"Behind the Science magazine","image":{"src":"/media/ukvllwft/vaccine-manufacturing-production-line-2.jpg?width=329&height=185&format=webp&quality=100&v=1dba2ebb585f130&hmac=c3e21840aa4184183d7a56b6b9e51c276f4c0cfa99faddf0b2e96abade984999","alt":"Scientist works in a futurist vaccine laboratory for GSK","darkModeSrc":"/media/ukvllwft/vaccine-manufacturing-production-line-2.jpg?width=329&height=185&format=webp&quality=50&v=1dba2ebb585f130&hmac=1ee1d1cba0cbe920daab92982b410dfd5be6b812ffb18d46bc5a1b15dc8ea9e4"},"link":{"text":"Spotlight on","href":"/en-gb/behind-the-science-magazine/","openInNewWindowText":null}},{"text":"Podcasts","image":{"src":"/media/tifb3jbw/bts-podcast-cover.jpg?rxy=0.3396812535345467,0.7098154172768643&width=329&height=185&format=webp&quality=100&v=1dc8ade65132ac0&hmac=8516fcec0699f0af4c0d1d3a3cb506fb47fd5a221d6a501a81eeb2c68f1c1998","alt":"Behind the science podcast cover ","darkModeSrc":"/media/tifb3jbw/bts-podcast-cover.jpg?rxy=0.3396812535345467,0.7098154172768643&width=329&height=185&format=webp&quality=50&v=1dc8ade65132ac0&hmac=e1517c1889bf48d5e31af2d9cfabe3dfbeee773f9a250a984d718db749944c52"},"link":{"text":"Spotlight on","href":"/en-gb/media/podcasts/","openInNewWindowText":null}}]},{"tooltip":null,"hasBorderRight":false,"title":"Careers","url":"/en-gb/careers/","nodes":[{"title":"Search jobs","url":"/en-gb/careers/search-jobs/","nodes":[],"isActive":false},{"title":"Featured careers","url":"/en-gb/careers/featured-careers/","nodes":[{"title":"A career in data","url":"/en-gb/careers/featured-careers/a-career-in-data/","nodes":[],"isActive":false}],"isActive":false},{"title":"Life at GSK","url":"/en-gb/careers/life-at-gsk/","nodes":[],"isActive":false},{"title":"Outstanding people","url":"/en-gb/careers/outstanding-people/","nodes":[{"title":"Great place to work","url":"/en-gb/careers/outstanding-people/great-place-to-work/","nodes":[],"isActive":false},{"title":"Meet our veterans","url":"/en-gb/careers/outstanding-people/meet-our-veterans/","nodes":[],"isActive":false},{"title":"Working together","url":"/en-gb/careers/outstanding-people/working-together/","nodes":[],"isActive":false},{"title":"My GSK story","url":"/en-gb/careers/outstanding-people/my-gsk-story/","nodes":[],"isActive":false},{"title":"Innovating together","url":"/en-gb/careers/outstanding-people/innovating-together/","nodes":[],"isActive":false}],"isActive":false},{"title":"Experienced professionals","url":"/en-gb/careers/experienced-professionals/","nodes":[{"title":"Business operations","url":"/en-gb/careers/experienced-professionals/business-operations/","nodes":[],"isActive":false},{"title":"Engineering at GSK ","url":"/en-gb/careers/experienced-professionals/engineering/","nodes":[],"isActive":false},{"title":"Global supply chain","url":"/en-gb/careers/experienced-professionals/global-supply-chain/","nodes":[],"isActive":false},{"title":"Sales and marketing","url":"/en-gb/careers/experienced-professionals/sales-and-marketing/","nodes":[],"isActive":false},{"title":"Research and development","url":"/en-gb/careers/experienced-professionals/research-and-development/","nodes":[{"title":"Chemical Manufacturing and Controls (CMC), Medicine Development and Supply (MDS)","url":"/en-gb/careers/experienced-professionals/research-and-development/chemical-manufacturing-and-controls-cmc-medicine-development-and-supply-mds/","nodes":[],"isActive":false},{"title":"Genomic sciences","url":"/en-gb/careers/experienced-professionals/research-and-development/genomic-sciences/","nodes":[],"isActive":false}],"isActive":false},{"title":"Technology","url":"/en-gb/careers/experienced-professionals/technology/","nodes":[],"isActive":false}],"isActive":false},{"title":"Early careers","url":"/en-gb/careers/early-careers/","nodes":[{"title":"Application process","url":"/en-gb/careers/early-careers/application-process/","nodes":[],"isActive":false},{"title":"Apprentice programmes","url":"/en-gb/careers/early-careers/apprentice-programmes/","nodes":[],"isActive":false},{"title":"Internships and placements","url":"/en-gb/careers/early-careers/internships-and-placements/","nodes":[],"isActive":false},{"title":"Graduate programme","url":"/en-gb/careers/early-careers/graduate-programme/","nodes":[{"title":"Business operations","url":"/en-gb/careers/early-careers/graduate-programme/business-operations/","nodes":[],"isActive":false},{"title":"Engineering","url":"/en-gb/careers/early-careers/graduate-programme/engineering/","nodes":[],"isActive":false},{"title":"Manufacturing & supply","url":"/en-gb/careers/early-careers/graduate-programme/manufacturing-supply/","nodes":[],"isActive":false},{"title":"Commercial ","url":"/en-gb/careers/early-careers/graduate-programme/commercial/","nodes":[],"isActive":false},{"title":"Research & development","url":"/en-gb/careers/early-careers/graduate-programme/research-development/","nodes":[],"isActive":false},{"title":"Manufacturing sciences & technology","url":"/en-gb/careers/early-careers/graduate-programme/manufacturing-sciences-technology/","nodes":[],"isActive":false}],"isActive":false},{"title":"Post graduate opportunities","url":"/en-gb/careers/early-careers/post-graduate-opportunities/","nodes":[],"isActive":false},{"title":"Frequently asked questions","url":"/en-gb/careers/early-careers/frequently-asked-questions/","nodes":[],"isActive":false}],"isActive":false},{"title":"Veterans","url":"/en-gb/careers/veterans/","nodes":[],"isActive":false},{"title":"Our global and regional hubs","url":"/en-gb/careers/our-global-and-regional-hubs/","nodes":[],"isActive":false},{"title":"How we hire","url":"/en-gb/careers/how-we-hire/","nodes":[{"title":"Fraudulent internet recruitment activities","url":"/en-gb/careers/how-we-hire/fraudulent-internet-recruitment-activities/","nodes":[],"isActive":false},{"title":"Frequently asked questions","url":"/en-gb/careers/how-we-hire/frequently-asked-questions/","nodes":[],"isActive":false}],"isActive":false}],"isActive":false,"promos":[{"text":"Outstanding people","image":{"src":"/media/kgwp0dc5/sddefault-2.jpg?rxy=0.425,0.51807228915662651&width=329&height=185&format=webp&quality=100&v=1dba2eba773f3d0&hmac=9e8e9da5bd3ca0619cfd47c6274f5ecbae61a5b73808bbd57b4fdffa469f2037","alt":"Angeles sitting on a sofa in a pink shirt","darkModeSrc":"/media/kgwp0dc5/sddefault-2.jpg?rxy=0.425,0.51807228915662651&width=329&height=185&format=webp&quality=50&v=1dba2eba773f3d0&hmac=25f6331ff89b8ea1f896e23e1cc935cee241b346efb1b08bd5aa5b5aa0d4e09c"},"link":{"text":"Spotlight on","href":"/en-gb/careers/outstanding-people/","openInNewWindowText":null}},{"text":"Inclusion","image":{"src":"/media/2u2dowa1/web16-header-stvg_2_2022_port_13_hess_nav.jpg?width=329&height=185&format=webp&quality=100&v=1dba2ebc1b88030&hmac=12ac7ded8bd7ab6e4665214fcc035ed44c079abcb2fbda20ea2220be73c1f12e","alt":"Lab technician smiling","darkModeSrc":"/media/2u2dowa1/web16-header-stvg_2_2022_port_13_hess_nav.jpg?width=329&height=185&format=webp&quality=50&v=1dba2ebc1b88030&hmac=a50405e6d858c131f8bc642c26ae3a9fb06154803458a748320a0ff3ec9c7e2f"},"link":{"text":"Spotlight on","href":"/en-gb/responsibility/inclusion/","openInNewWindowText":null}}]}],"skipToContent":"Skip to content","skipToSearch":"Skip to search","typeaheadSearch":{"apiEndpoint":"api/search/typeahead?siteContainerId=1703","searchFieldPlaceholderText":"Enter a search term...","searchPage":"/en-gb/search/","ariaLabel":"Submit form"},"ariaLabel":"Global navigation"},"footer":{"logo":null,"copyrightText":"This is our global website, intended for visitors seeking information on GSK's worldwide business. Our market sites can be reached by visiting our location selector.
\n\n
© 2001-2026 GSK plc. All rights reserved. Trade marks are owned by or licensed to the GSK group of companies.
\nGSK plc. Registered in England and Wales No. 3888792.
\nRegistered office: 79 New Oxford Street, London. United Kingdom. WC1A 1DG
","modernSlaveryStatement":{"name":"Modern Slavery Act Statement 2025","url":"/media/5ladhmeu/modern-slavery-act-statement-2025.pdf","fileExtension":"PDF","fileSize":"187.7KB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window"},"sections":{"socialMedia":{"columnTitle":"Follow us on:","socialMediaItems":[{"globalLink":{"text":null,"href":"http://www.linkedin.com/company/glaxosmithkline","target":"_blank","openInNewWindowText":"Opens in a new window"},"localLink":null,"ariaLabel":"Visit GSK on Linkedin","customIcon":null,"showPopupMenu":false,"type":"LinkedIn"},{"globalLink":{"text":null,"href":"http://twitter.com/GSK","target":"_blank","openInNewWindowText":"Opens in a new window"},"localLink":null,"ariaLabel":"Visit GSK X page","customIcon":null,"showPopupMenu":false,"type":"X"},{"globalLink":{"text":null,"href":"https://bsky.app/profile/gsk.bsky.social/","target":"_blank","openInNewWindowText":"Opens in a new window"},"localLink":null,"ariaLabel":"","customIcon":null,"showPopupMenu":false,"type":"Bluesky"},{"globalLink":{"text":null,"href":"https://www.instagram.com/gsk/","target":"_blank","openInNewWindowText":"Opens in a new window"},"localLink":null,"ariaLabel":"Visit GSK Instagram","customIcon":null,"showPopupMenu":false,"type":"Instagram"},{"globalLink":{"text":null,"href":"https://www.facebook.com/GSK","target":"_blank","openInNewWindowText":"Opens in a new window"},"localLink":null,"ariaLabel":"Visit GSK Facebook page","customIcon":null,"showPopupMenu":false,"type":"Facebook"},{"globalLink":{"text":null,"href":"http://www.youtube.com/GSK","target":"_blank","openInNewWindowText":"Opens in a new window"},"localLink":null,"ariaLabel":"Visit GSK YouTube Channel","customIcon":null,"showPopupMenu":false,"type":"Youtube"},{"globalLink":{"text":null,"href":"/en-gb/media/rss-feeds/","openInNewWindowText":null},"localLink":null,"ariaLabel":"Visit GSK RSS feeds","customIcon":null,"showPopupMenu":false,"type":"Rss"}]},"columns":[{"columnTitle":"GSK websites","links":[{"text":"Locations selector","href":"/en-gb/locations/","openInNewWindowText":null},{"text":"Social media directory","href":"/en-gb/media/social-media/","openInNewWindowText":null},{"text":"GSKPro for healthcare professionals","href":"https://www.gskpro.com","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"GSK study register","href":"https://www.gsk-studyregister.com/en/","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"Supplier website","href":"https://supplier.gsk.com","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"ViiV Healthcare","href":"https://viivhealthcare.com/","target":"_blank","openInNewWindowText":"Opens in a new window"}]},{"columnTitle":"Quick links","links":[{"text":"Behind the Science magazine","href":"/en-gb/behind-the-science-magazine/","openInNewWindowText":null},{"text":"Company","href":"/en-gb/company/","openInNewWindowText":null},{"text":"Innovation","href":"/en-gb/innovation/","openInNewWindowText":null},{"text":"Products","href":"/en-gb/products/","openInNewWindowText":null},{"text":"Responsibility","href":"/en-gb/responsibility/","openInNewWindowText":null},{"text":"Investors","href":"/en-gb/investors/","openInNewWindowText":null},{"text":"Media","href":"/en-gb/media/","openInNewWindowText":null},{"text":"Careers","href":"/en-gb/careers/","openInNewWindowText":null}]},{"columnTitle":"Get in touch","links":[{"text":"Contact us","href":"/en-gb/contact-us/","openInNewWindowText":null},{"text":"Partnerships","href":"/en-gb/innovation/partnerships/","openInNewWindowText":null},{"text":"Report a possible side effect","href":"/en-gb/contact-us/report-a-possible-side-effect/","openInNewWindowText":null},{"text":"GSK Speak up","href":"https://www.gsk.com/speakup","target":"_blank","openInNewWindowText":"Opens in a new window"}]}]},"bottomLinks":[{"text":"Accessibility","href":"/en-gb/accessibility/","openInNewWindowText":null},{"text":"Digital sustainability","href":"/en-gb/digital-sustainability/","openInNewWindowText":null},{"text":"Terms of use","href":"/en-gb/terms-of-use/","openInNewWindowText":null},{"text":"Cookie policy","href":"/en-gb/cookie-policy/","openInNewWindowText":null},{"text":"Privacy notice","href":"https://privacy.gsk.com/en-gb/privacy-notice/general","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"Sitemap","href":"/en-gb/sitemap/","openInNewWindowText":null}],"continueToLink":null,"legalApprovalText":""},"sharing":{"description":"Respiratory treatments are undergoing a sustainability transformation to reduce their impact on the environment","og":[{"property":"og:title","content":"‘Putting patients first means caring about the air they breathe – and reducing the impact of respiratory care on the environment’"},{"property":"og:description","content":"Respiratory treatments are undergoing a sustainability transformation to reduce their impact on the environment"},{"property":"og:image","content":"https://www.gsk.com/media/pwugpq2r/patientinnaturerespisustainabilityshutterstock.jpg?rxy=0.66833333333333333,0.525&width=600&format=webp&quality=100&v=1dba2eb9a201650&hmac=d0a962faa2bb19e1ff8b8eb73deb215b79504212bdebc790115fe487e254c1fd"},{"property":"og:url","content":"https://www.gsk.com/en-gb/behind-the-science-magazine/respiratory-disease-sustainability-climate-change/"}],"twitter":[{"name":"twitter:card","content":"summary_large_image"},{"name":"twitter:site","content":"@gsk"},{"name":"twitter:title","content":"‘Putting patients first means caring about the air they breathe – and reducing the impact of respiratory care on the environment’"},{"name":"twitter:description","content":"Respiratory treatments are undergoing a sustainability transformation to reduce their impact on the environment"},{"name":"twitter:image","content":"https://www.gsk.com/media/pwugpq2r/patientinnaturerespisustainabilityshutterstock.jpg?rxy=0.66833333333333333,0.525&width=600&format=webp&quality=100&v=1dba2eb9a201650&hmac=d0a962faa2bb19e1ff8b8eb73deb215b79504212bdebc790115fe487e254c1fd"},{"name":"twitter:url","content":"https://www.gsk.com/en-gb/behind-the-science-magazine/respiratory-disease-sustainability-climate-change"}]},"stickyShare":{"href":"https://www.gsk.com/en-gb/behind-the-science-magazine/respiratory-disease-sustainability-climate-change/","pageTitle":"‘Putting patients first means caring about the air they breathe – and reducing the impact of respiratory care on the environment’","shareText":"Share","newTabLinkText":"Opens in a new window","shareOnTwitterText":"Share on Twitter","shareOnLinkedInText":"Share on LinkedIn","shareOnFacebookText":"Share on Facebook"},"exitSitePreferences":{"popupEnabled":false,"title":"","texts":"","continueText":"Continue","cancelText":"Cancel","exclusionUrls":[]},"settings":{"optionalStylesheetLink":null,"themeColorHexCode":null,"headerLogoLightTheme":null,"headerLogoDarkTheme":null,"footerLogo":{"src":"https://www.gsk.com/media/0jwou3xu/gsk-logo.png?width=104&format=webp&quality=100&v=1dbf4b05a4e6470&hmac=88eee08ffc4c7e7b930ebd265a76bc829fe24564389a8e6d463f844dfe83fef8","alt":"Gsk Logo","darkModeSrc":"https://www.gsk.com/media/0jwou3xu/gsk-logo.png?width=104&format=webp&quality=50&v=1dbf4b05a4e6470&hmac=994d785e3ecfaac6bc9c67bacc48b0c287fa77e4c4f0d3de82d33bb48be5efda"},"scripts":[{"pageLocation":"Top","text":" \n"}],"globalWebsiteLink":null,"googleMapsApiKey":"AIzaSyA2QMg4Ww6djPKb7b9BraQn4kgJmDaLblg","textToSpeechApiKey":"70ab0a79-1d92-4286-86d2-abdd71cc785c","bingVerificationCode":"","googleAnalytics":"","siteTitle":" | GSK"},"pageSettings":{"disableBackToTopButton":false,"backToTopButtonText":"Back to top","robotsNoFollow":false,"robotsNoIndex":false,"canonicalUrl":"https://www.gsk.com/en-gb/behind-the-science-magazine/respiratory-disease-sustainability-climate-change/"},"tealiumSettings":{"enabled":false,"data":""},"entryPopup":null,"protectedPage":false,"schema":{"jsonLdSchemas":["{\"@context\":\"https://schema.org\",\"@type\":\"Article\",\"description\":\"Respiratory treatments are undergoing a sustainability transformation to reduce their impact on the environment\",\"image\":{\"@type\":\"ImageObject\",\"image\":\"https://www.gsk.com/media/pwugpq2r/patientinnaturerespisustainabilityshutterstock.jpg\"},\"mainEntityOfPage\":\"https://www.gsk.com/en-gb/behind-the-science-magazine/respiratory-disease-sustainability-climate-change/\",\"url\":\"https://www.gsk.com/en-gb/behind-the-science-magazine/respiratory-disease-sustainability-climate-change/\",\"author\":{\"@type\":\"Person\",\"name\":\"Dr David Lipson\",\"description\":\"Dr David Lipson supports the development of the respiratory disease area strategy and helps oversee the clinical studies and expansion activities for the GSK respiratory portfolio. David works closely with members of the early research group helping to design the development plans for early assets within the GSK pipeline, and reviews respiratory business development opportunities to further expand the respiratory portfolio. He is also an Adjunct Associate Professor of Medicine at the Perelman School of Medicine, University of Pennsylvania.\",\"JobTitle\":\"Vice President and Clinical Research Head, Respiratory and Immunology R\\u0026D at GSK\",\"image\":{\"@type\":\"ImageObject\",\"image\":\"https://www.gsk.com/media/ocehjuh4/lipson-crop.png\"}},\"datePublished\":\"2024-09-04T00:00:00+00:00\",\"headline\":\"\\u2018Putting patients first means caring about the air they breathe \\u2013 and reducing the impact of respiratory care on the environment\\u2019\",\"keywords\":\"Respiratory,Immunology,Environmental sustainability,Specialty\",\"articleBody\":\"Climate change and air pollution negatively impact the health of patients with respiratory conditions \\u2013 and yet some treatments used for those same conditions contribute to greenhouse gas emissions. Here, Dr David Lipson, GSK\\u2019s Vice President and Clinical Research Head, Respiratory and Immunology R\\u0026amp;D, explains why a focus on sustainability in respiratory care is therefore essential \\u2013 and how GSK is innovating to benefit both patients and the planet.Climate change is one of the greatest threats to human health, and its impact on patients with respiratory health conditions should not be underestimated.Extreme weather creates better conditions for respiratory infections to thrive in, while common pollutants, caused by things like vehicle exhausts and deforestation, can irritate the airways,\\u00A0sometimes with fatal results. It is estimated that air pollution is responsible for the premature deaths of around 7 million patients every year, whose ischemic heart disease, stroke, chronic obstructive pulmonary disease (COPD), lung cancer and acute respiratory infections are worsened by it.\\u00A0At the same time, we know that chronic respiratory treatments, like metered dose inhalers (MDIs), and hospitalisations are a large contributor to the carbon footprint of healthcare systems \\u2013 which account for 4.4% of the global total of greenhouse gas emissions. To put it into perspective: if healthcare systems were a country, it would be the fifth largest emitter on the planet.We have been leaders in the prevention and treatment of respiratory disease for more than five decades. We have developed an industry leading approach to sustainability, with an ambition to achieve a 90% reduction in carbon emissions by 2045, as well as to contribute to a nature positive world, which includes company targets and action on water, waste, land use and biodiversity. \\u00A0As such, it makes sense that teams leading on respiratory care, like those at GSK, are determined to break this negative cycle by focusing on making respiratory care more sustainable.Sustainable designEmbedding sustainability by design into new respiratory vaccines, medicines, packaging, and supply chains could significantly reduce impact on the environment.\\u00A0That\\u2019s why we\\u2019ve created \\u2018Sustainable Design Plans\\u2019 for all our newly developed or acquired medicines. These are now fully integrated to ensure we are building sustainability into the entire product design and development process.During the drug development process, our Research and Development team apply principles of \\u2018green chemistry\\u2019, taking action to minimise the creation of waste and the amount of energy needed in the manufacturing process.Plus we partner with industry peers to help our shared suppliers reduce their carbon emissions through programmes like Energize that make it easier for suppliers to access renewable electricity sources. And we\\u2019re working to reduce the environmental impact of our packaging by being a founding member of the Circularity in Primary Pharmaceutical Packaging Accelerator (CiPPPA), which brings together partners from across the sector to address the sustainable packaging of medicines and vaccines.We\\u2019re also applying these eco design principles to respiratory care. Metered dose inhalers (MDIs) are essential for many patients, but the propellants currently used in all MDIs to push the medicine into a person\\u2019s airways contributes to greenhouse gas emissions. We are currently in clinical trials looking at a next generation propellant, which, if successful, could reduce MDI emissions by approximately 90%.At the same time, we\\u2019re developing the next generation of respiratory treatments and preventions for millions of people with sustainability woven into every stage of the process \\u2013 from the energy we use during discovery to the packaging it comes in and the way it is delivered.Intervening earlyIntervening earlier in the course of respiratory disease is another way we can protect patients and the planet.Asthma and COPD are both chronic inflammatory conditions driven by genetic and environmental factors. As such, they are complex and often poorly controlled, leading to increased treatments, doctor visits and hospitalisations, all of which are key drivers of greenhouse gas emissions within healthcare systems.Earlier diagnosis and improved, patient-centred treatment regimens that consider the biological uniqueness of an individual\\u2019s respiratory disease can potentially reduce the risk of exacerbations \\u2013 or attacks \\u2013 and permanent damage to the lungs. This can help patients manage their symptoms more effectively, keeping them out of hospital and preventing them from developing comorbidities that could end up needing more treatment.We also have an opportunity to make better use of treatment innovations to optimise patient care and therefore reduce the impact of traditional care on the environment.\\u00A0For example, where appropriate, patients can be prescribed advanced longer-acting therapies, or a propellant-free Dry Powder Inhaler (DPI), both of which can help them achieve clinical benefits while significantly cutting carbon emissions.And it\\u2019s important to protect patients against common respiratory diseases through vaccination, as they are more likely to develop severe complications from infections. This is better for patient outcomes, and emerging data shows that preventing diseases through vaccination is far more sustainable than treating disease.Ahead togetherBut we can\\u2019t do it alone.The path to delivering more sustainable respiratory care must involve partners across the healthcare system pulling together: from industry collaboration to change supply chains, to teaming up with regulators and payers to ensure the uptake of sustainable medicines and vaccines. We also need to support healthcare professionals to prescribe sustainable treatments and patients to use them.The challenge might be complex, but we share the same air and the same goal \\u2013 better health outcomes with a lower impact on our environment.Together we can deliver solutions that move us forward towards a respiratory care that is better for both patients and the planet.\",\"articleSection\":\"Behind the Science magazine - Opinion\"}"]}}